Factors associated with participation in a proton therapy clinical trial: a cross-sectional survey of Danish patients with head and neck cancer
DOI:
https://doi.org/10.2340/1651-226X.2025.43912Keywords:
Neoplasms, Head and Neck, Radiotherapy, Proton Beam Therapy, Clinical Trials as Topic, Patient Participation, Health Literacy, Surveys and Questionnaires, Socioeconomic FactorsAbstract
Background and purpose: Participation in proton therapy (PT) trials may be affected by structural, clinical, and individual factors, potentially excluding certain patient groups. Such disparities can lead to unequal access to potential research benefits and may limit the generalisability of trial findings. This study aimed to identify factors associated with participation in a Danish randomised controlled trial (RCT) comparing proton versus photon radiotherapy for head and neck cancer.
Patients and methods: This national cross-sectional study invited patients with pharyngeal and laryngeal cancer, referred for curative-intent radiotherapy at seven Danish radiotherapy clinics between 2022 and 2025, to complete a survey. Respondents were categorised based on enrollment status in a national RCT comparing proton versus photon radiotherapy. Clinical, demographic, psychosocial, and lifestyle data were collected and linked to clinical registry data. Multiple logistic regression was used to assess exposure variables associated with trial participation.
Results: Of 304 respondents, 120 (39%) were enrolled in the RCT. Female gender, older age, greater geographical distance to the PT centre, mobility limitations, lower self-rated health status, and lower ability to actively engage with healthcare providers (Health Literacy Questionnaire scale 6) were significantly associated with lower odds of participation. No significant associations were observed for income, education, marital status, or anxiety.
Interpretation: The findings indicate that demographic, geographical, functional, and communication-related factors may limit participation in PT trials. This highlights the need for interventions that enhance the delivery of trial information, strengthen communication between patients and healthcare professionals, and support informed clinical trial decision-making.
Downloads
References
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72.
https://doi.org/10.1056/NEJMra1715715 DOI: https://doi.org/10.1056/NEJMra1715715
Ingarfield K, McMahon AD, Hurley K, Toms S, Pring M, Thomas SJ, et al. Inequality in survival of people with head and neck cancer: head and neck 5000 cohort study. Head Neck. 2021;43(4):1252–70.
https://doi.org/10.1002/hed.26589 DOI: https://doi.org/10.1002/hed.26589
Olsen MH, Kjær TK, Dalton SO. Social ulighed i kræft i Danmark. Kræftens Bekæmpelses Center for Kræftforskning; Copenhagen, 2019.
Olsen MH, Bøje CR, Kjær TK, Steding-Jessen M, Johansen C, Overgaard J, et al. Socioeconomic position and stage at diagnosis of head and neck cancer – a nationwide study from DAHANCA. Acta Oncol. 2015;54(5):759–66.
https://doi.org/10.3109/0284186X.2014.998279 DOI: https://doi.org/10.3109/0284186X.2014.998279
Dalton SO, Olsen MH, Johansen C, Olsen JH, Andersen KK. Socioeconomic inequality in cancer survival – changes over time. A population-based study, Denmark, 1987–2013. Acta Oncol. 2019;58(5):737–44.
https://doi.org/10.1080/0284186X.2019.1566772 DOI: https://doi.org/10.1080/0284186X.2019.1566772
Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020;151:149–51.
https://doi.org/10.1016/j.radonc.2020.07.037 DOI: https://doi.org/10.1016/j.radonc.2020.07.037
van der Laan HP, Van den Bosch L, Schuit E, Steenbakkers R, van der Schaaf A, Langendijk JA. Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer. Radiother Oncol. 2021;160:47–53.
https://doi.org/10.1016/j.radonc.2021.04.011 DOI: https://doi.org/10.1016/j.radonc.2021.04.011
Grau C, Durante M, Georg D, Langendijk JA, Weber DC. Particle therapy in Europe. Mol Oncol. 2020;14(7):1492–9.
https://doi.org/10.1002/1878-0261.12677 DOI: https://doi.org/10.1002/1878-0261.12677
Friborg J, Jensen K, Eriksen JG, Samsøe E, Maare C, Farhadi M, et al. Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer. Radiother Oncol. 2023;47(8):109958.
https://doi.org/10.1016/j.radonc.2023.109958 DOI: https://doi.org/10.1016/j.radonc.2023.109958
Eskander MF, Gil L, Beal EW, Li Y, Hamad A, Oppong B, et al. Access denied: inequities in clinical trial enrollment for pancreatic cancer. Ann Surg Oncol. 2022;29(2):1271–7.
https://doi.org/10.1245/s10434-021-10868-4 DOI: https://doi.org/10.1245/s10434-021-10868-4
Gad KT, Johansen C, Duun-Henriksen AK, Krøyer A, Olsen MH, Lassen U, et al. Socioeconomic differences in referral to phase I cancer clinical trials: a Danish matched cancer case-control study. J Clin Oncol. 2019;37(13):1111–19.
https://doi.org/10.1200/JCO.18.01983 DOI: https://doi.org/10.1200/JCO.18.01983
Gaito S, Aznar MC, Burnet NG, Crellin A, France A, Indelicato D, et al. Assessing equity of access to proton beam therapy: a literature review. Clin Oncol (R Coll Radiol). 2023;35(9):e528–36.
https://doi.org/10.1016/j.clon.2023.05.014 DOI: https://doi.org/10.1016/j.clon.2023.05.014
Burus T, VanHelene AD, Rooney MK, Lang Kuhs KA, Christian WJ, McNair C, et al. Travel-time disparities in access to proton beam therapy for cancer treatment. JAMA Netw Open. 2024;7(5):e2410670.
https://doi.org/10.1001/jamanetworkopen.2024.10670 DOI: https://doi.org/10.1001/jamanetworkopen.2024.10670
Unger JM, Gralow JR, Albain KS, Ramsey SD, Hershman DL. Patient income level and cancer clinical trial participation: a prospective survey study. JAMA Oncol. 2016;2(1):137–9.
https://doi.org/10.1001/jamaoncol.2015.3924 DOI: https://doi.org/10.1001/jamaoncol.2015.3924
Javid SH, Unger JM, Gralow JR, Moinpour CM, Wozniak AJ, Goodwin JW, et al. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316). Oncologist. 2012;17(9):1180–90.
https://doi.org/10.1634/theoncologist.2011-0384 DOI: https://doi.org/10.1634/theoncologist.2011-0384
Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst. 2019;111(3):245–55.
https://doi.org/10.1093/jnci/djy221 DOI: https://doi.org/10.1093/jnci/djy221
Kjaer T, Johansen C, Andersen E, Karlsen R, Nielsen AL, Frederiksen K, et al. Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark. J Cancer Surviv. 2016;10(2):251–60.
https://doi.org/10.1007/s11764-015-0471-x DOI: https://doi.org/10.1007/s11764-015-0471-x
Ousseine YM, Bouhnik AD, Mancini J. Health literacy and clinical trial participation in French cancer patients: a national survey. Curr Oncol. 2022;29(5):3118–29.
https://doi.org/10.3390/curroncol29050253 DOI: https://doi.org/10.3390/curroncol29050253
Unger JM, Hershman DL, Till C, Minasian LM, Osarogiagbon RU, Fleury ME, et al. ‘When offered to participate’: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst. 2021;113(3):244–57.
https://doi.org/10.1093/jnci/djaa155 DOI: https://doi.org/10.1093/jnci/djaa155
Gad KT, Lassen U, Duun-Henriksen AK, Dalton SO, Mau-Sørensen M, Bidstrup PE, et al. Patients in phase 1 cancer trials: psychological distress and understanding of trial information. Acta Oncol. 2022;61(3):341–8.
https://doi.org/10.1080/0284186X.2021.1993331 DOI: https://doi.org/10.1080/0284186X.2021.1993331
Wilhøft Kristensen A, Lunde Jensen A, Jensen K, Oksbjerre Dalton S, Friborg J, Grau C. Exploring patient-reported barriers to participating in proton therapy clinical trials. Tech Innov Patient Support Radiat Oncol. 2024;29:100230.
https://doi.org/10.1016/j.tipsro.2023.100230 DOI: https://doi.org/10.1016/j.tipsro.2023.100230
Zabor EC, Kaizer AM, Hobbs BP. Randomized controlled trials. Chest. 2020;158(1S):S79–87.
https://doi.org/10.1016/j.chest.2020.03.013 DOI: https://doi.org/10.1016/j.chest.2020.03.013
Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, et al. NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncol. 2019;58(10):1410–15.
https://doi.org/10.1080/0284186X.2019.1654129 DOI: https://doi.org/10.1080/0284186X.2019.1654129
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
https://doi.org/10.1016/j.jbi.2019.103208 DOI: https://doi.org/10.1016/j.jbi.2019.103208
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
https://doi.org/10.1016/j.jbi.2008.08.010 DOI: https://doi.org/10.1016/j.jbi.2008.08.010
Overgaard J, Jovanovic A, Godballe C, Grau Eriksen J. The Danish head and neck cancer database. Clin Epidemiol. 2016;8:491–6.
https://doi.org/10.2147/CLEP.S103591 DOI: https://doi.org/10.2147/CLEP.S103591
UNESCO. International Standard Classification of Education (ISCED). 2011. [cited 2025 Apr 22] Available from: https://uis.unesco.org/sites/default/files/documents/international-standard-classification-of-education-isced-2011-en.pdf
Danmarks Statistik. Income. 2025. [cited 2025 Apr 22] Available from: https://www.dst.dk/da/Statistik/kommunekort/indkomster
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
https://doi.org/10.1001/archinte.166.10.1092 DOI: https://doi.org/10.1001/archinte.166.10.1092
Osborne RH, Batterham RW, Elsworth GR, Hawkins M, Buchbinder R. The grounded psychometric development and initial validation of the Health Literacy Questionnaire (HLQ). BMC Public Health. 2013;13:658.
https://doi.org/10.1186/1471-2458-13-658 DOI: https://doi.org/10.1186/1471-2458-13-658
Maindal HT, Kayser L, Norgaard O, Bo A, Elsworth GR, Osborne RH. Cultural adaptation and validation of the Health Literacy Questionnaire (HLQ): robust nine-dimension Danish language confirmatory factor model. Springerplus. 2016;5(1):1232.
https://doi.org/10.1186/s40064-016-2887-9 DOI: https://doi.org/10.1186/s40064-016-2887-9
Rabin R, de Charro F, Herdman M, Gudex C, Lloyd A, Janssen M, et al. EQ-5D: a measure of health status from the EuroQol Group Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Ann Med. 2001;33(5):337–43.
https://doi.org/10.3109/07853890109002087 DOI: https://doi.org/10.3109/07853890109002087
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.
https://doi.org/10.1007/s11136-011-9903-x DOI: https://doi.org/10.1007/s11136-011-9903-x
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
https://doi.org/10.1016/0021-9681(87)90171-8 DOI: https://doi.org/10.1016/0021-9681(87)90171-8
Lilja-Fischer JK, Kristensen MH, Lassen P, Steiniche T, Tramm T, Stougaard M, et al. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer. Acta Oncol. 2023;62(11):1384–8.
https://doi.org/10.1080/0284186X.2023.2266127 DOI: https://doi.org/10.1080/0284186X.2023.2266127
Nowicka-Matus K, Friborg J, Hansen CR, Bernsdorf M, Elstrøm UV, Farhadi M, et al. Acute toxicities in proton therapy for head and neck cancer – a matched analysis of the DAHANCA 35 feasibility study. Clin Transl Radiat Oncol. 2024;48:100835.
https://doi.org/10.1016/j.ctro.2024.100835 DOI: https://doi.org/10.1016/j.ctro.2024.100835
The Danish Head and Neck Cancer Study Group. DAHANCA]. 2024. [cited 2025 May 7] Available from: https://www.dahanca.dk/
NORDCAN. Oropharynx. 2024. [cited 2025 May 15] Available from: https://gco.iarc.fr/media/nordcan/factsheets/94/dk/countries/208/oropharynx-40-danmark-208.pdf
Sedrak MS, Freedman RA, Cohen HJ, Muss HB, Jatoi A, Klepin HD, et al. Older adult participation in cancer clinical trials: a systematic review of barriers and interventions. CA Cancer J Clin. 2021;71(1):78–92.
https://doi.org/10.3322/caac.21638 DOI: https://doi.org/10.3322/caac.21638
Thijssen SV, Boersma LJ, Heising L, Swart RR, Ou CXJ, Roumen C, et al. Clues to address barriers for access to proton therapy in the Netherlands. Radiother Oncol. 2023;178:109432.
https://doi.org/10.1016/j.radonc.2022.11.021 DOI: https://doi.org/10.1016/j.radonc.2022.11.021
Bourke S, Bennett B, Oluboyede Y, Li T, Longworth L, O’Sullivan SB, et al. Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer. Health Qual Life Outcomes. 2024;22(1):81.
https://doi.org/10.1186/s12955-024-02294-3 DOI: https://doi.org/10.1186/s12955-024-02294-3
Green H, Rieu R, Slevin F, Ashmore L, Bulbeck H, Gkogkou P, et al. Best practice for patient-centred radiotherapy in clinical trials and beyond – a national multidisciplinary consensus. Clin Oncol (R Coll Radiol). 2025;39:103732.
https://doi.org/10.1016/j.clon.2024.103732 DOI: https://doi.org/10.1016/j.clon.2024.103732
Trezona A, Dodson S, Osborne RH. Development of the organisational health literacy responsiveness (Org-HLR) framework in collaboration with health and social services professionals. BMC Health Serv Res. 2017;17(1):513.
https://doi.org/10.1186/s12913-017-2465-z DOI: https://doi.org/10.1186/s12913-017-2465-z
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Anne Wilhøft Kristensen, Kenneth Jensen, Annesofie L. Jensen, Susanne O. Dalton, Jesper Eriksen, Jeppe Friborg, Cai Grau
This work is licensed under a Creative Commons Attribution 4.0 International License.
